Neurology

Industry executives reveal how profits drive rising prices for MS drugs

U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year.

Source link




Related posts

Changes in cerebral autoregulation and blood biomarkers after remote ischemic preconditioning

Newsemia

neurosciencenews: PTSD has strong genetic component like other…

Newsemia

Map of broken brain networks shows why people lose speech in language-based dementia

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy